11/10-14/25 Weekly Market Recap - Movers, Macro, Monetary, and Fiscal

Week 11/10/25 - 11/14/25

Weekly Market Summary by Aremorph


Summary - Movers, Macro, Monetary, and Fiscal


Global Weekly Movements

U.S. Equities

  • S&P 500 Index: 6,734.11 (-0.76%)

  • Dow Jones Industrial Average: 47,147.48 (0.11%)

  • Russell 3000 Index:  3,814.72 (-0.74%)

  • NASDAQ Composite: 22,900.59 (-1.95%)

  • Big Movers of the Week 

    • Iron Mountain (IRM): 91.37 (-12.25%)

    • Dell (DELL): 133.76 (-8.82%)

    • CoinBase (COIN): 284.0 (-8.13%)

    • Eli Lilly (LLY): 1025.28 (10.92%)

    • Albemarle (ALB): 115.14 (18.48%)

Chinese Equities - Shanghai Composite (SHCOMP): 3,990.49 (-0.28%)

Hong Kong Equities - Hang Seng Index (HSI): 26,572.46 (0.96%)

Japanese Equities- Nikkei 2225 (NI225): 50,376.53 (-0.53%)

European Equities 

  • UK Index (UKX): 9,698.37 (0.16%)

  • German Index (DAX): 23,876.55 (-0.20%)

Commodities

  • Gold Futures: 4,084.4 (0.55%)

  • Crude Oil Futures: 59.81 (-0.42%)


U.S. Monetary & Fiscal Policy:

Long Way From Parity: Over the past year, the U.S. dollar has steadily weakened against the Euro. With a peak of strength earlier this year at near parity, the dollar has now shifted to 1.18 per Euro. With EUR/USD at 1.18, this signifies the relative cheapness for international investors looking at U.S. assets. This can drive investment from American investors back into domestic equities and alternative assets like crypto. Moreover, domestic firms with heavy FX revenue benefit. 


Shut Down Ends: The historic 43 day U.S. government shutdown ended after President Trump signed a stopgap spending bill. The closure strained the economy, disrupted flights, halted food aid, and left federal workers unpaid for over a month. The new funding only runs through Jan. 30, setting up another potential showdown early next year. Democrats opposed the deal because it didn’t renew key Affordable Care Act subsidies, while Republicans framed the resolution as a political win. Even with the government reopening, agencies warn it could take days or weeks to fully recover from the backlog.


Global Macroeconomic News:

Pfizer Bests Novo Nordisk:  Pfizer has won the high stakes bidding war against Novo Nordisk for the acquisition of Metsera, valued at $10 Billion. With the addition of obesity focused drug candidates, Pfizer aims to hijack market share as their own drug failed during the research and development stage. This deal aims to strengthen Pfizer as they look to diversify beyond their aging COVID-era portfolio as the GLP-1 developments create global tensions among biotech companies. 


SoftBank Sells: SoftBank sold its entire $5.8B Nvidia stake to bankroll a new wave of AI bets, including major projects with OpenAI, Oracle, and a massive planned AI hub in Arizona. The move comes as investors question whether the industry’s trillion-dollar AI spending spree can actually deliver returns, sending SoftBank’s stock down more than 10%. Even so, soaring valuations in names like OpenAI and Arm helped SoftBank post a huge $16.2B quarterly profit. The company is doubling down with deals for Ampere Computing $6.5B and ABB’s robotics arm $5.4B, backed by fresh financing. SoftBank’s shares have jumped 78% over the past quarter, but analysts warn the easy “cheap AI exposure” trade may be over.



Sources: Google Finance, Market Watch, CME Fedwatch, Yahoo Finance, Reuters, New York Times, Bloomberg, Wall St Journal, Washington Post, US Department of the Treasury, Zacks


Have a great week investing!

Sincerely,
Aremorph






Comments

Popular posts from this blog

11/25-11/29/24 Weekly Market Recap - Movers, Macro, Monetary, and Fiscal

12/9-12/13/24 Weekly Market Recap - Movers, Macro, Monetary, and Fiscal

12/2-12/6/24 Weekly Market Recap - Movers, Macro, Monetary, and Fiscal